Connect with us

Press Release

CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China

Published

on

SHENZHEN, CHINA China Medical System Holdings Limited (CMS” or the Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by the Group on 22 April 2025 for details) received the acceptance from the National Medical Products Administration of China (NMPA) for the New Drug Application (NDA) of ruxolitinib phosphate cream (the Product”) for the treatment of mild to moderate atopic dermatitis on 24 February 2026. The Product is indicated for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. The NDA has been approved for inclusion in the Priority Review List by the Center for Drug Evaluation (CDE) of the NMPA based on its qualification as a new variety, dosage form and specification of pediatric drug that conforms to the physiological characteristics of children”, which is expected to accelerate the Product’s review process for marketing approval in the AD indication.

 

Impressive phase III trial data in AD

Its Priority Review is expected to accelerate its NDA approval

 

Ruxolitinib phosphate cream was approved for marketing by the NMPA in January 2026, becoming the first and only targeted drug approved in China for the treatment of vitiligo. The acceptance of this NDA for the additional indication of AD marks a key milestone in the Product’s expansion into multiple therapeutic areas.

 

Ruxolitinib phosphate cream has achieved positive results in a randomized, double-blind, placebo-controlled Phase III clinical trial in China for mild to moderate AD.

  1. Robust Efficacy: The Product successfully met its primary endpoint, demonstrating that a significantly higher proportion of subjects treated with ruxolitinib phosphate cream achieved IGA (Investigator’s Global Assessment) of 0 or 1 with at least two grades of reduction from baseline at week 8, compared with placebo (63.0% vs 9.2%, P < 0.001). For the key secondary endpoint, the proportion of subjects achieving at least a 75% improvement from baseline in the Eczema Area and Severity Index score (EASI 75) of treatment with ruxolitinib phosphate cream was also significantly higher than that of the placebo group, at week 8 (78.0% vs 15.4%, P < 0.001).
  2. Favorable Safety Profile: The severity of treatment-emergent adverse events (TEAE) during the treatment period was mostly mild or moderate, with no TEAEs leading to discontinuation of the study drug. Overall, ruxolitinib phosphate cream was safe and well-tolerated.

 

Furthermore, the NDA has been approved for inclusion in the Priority Review List. According to relevant NMPA regulations, the review timeline for marketing applications subject to Priority Review and Approval Procedure is substantially shortened—from the standard 200 days to 130 days. This significant reduction in the review timeline is expected to accelerate the marketing process of ruxolitinib phosphate cream for the AD indication, benefiting a wide range of patients at an earlier date.

 

Building an integrated AD solution,

strengthening Dermavons leadership in dermatology

 

AD is a chronic, recurrent and inflammatory dermatologic disease, with the main clinical manifestations of dry skin, chronic eczema-like lesions and obvious itching or pruritus, which may seriously affect the quality of life of patients. It is estimated that there were over 54 million AD patients in China as of 2024. Based on SCORAD scores, mild to moderate AD accounts for 98% of these cases, representing over 52.5 million patients[1]. Topical drugs are the most basic treatment for AD. Traditional topical medications such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) have clinical pain points with long-term adverse reactions or limited efficacy, therefore novel treatments are urgently needed.

 

Dermavon has developed a comprehensive treatment + care” integrated solution for AD. In addition to the topical formulation ruxolitinib phosphate cream for mild-to-moderate AD, the portfolio also includes the injectable biological agent Comekibart Injection (MG-K10) for moderate-to-severe AD, the oral small molecule targeted drug CMS-D001 for moderate-to-severe AD, and the Heling Soothing Product Series for daily repair, to meet the management needs of AD patients from treatment to daily care.

 

Simultaneously, the acceptance of the NDA for the AD indication will strengthen Dermavon’s strategic layout in the field of skin treatments and create synergies with its commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream), and a series of innovative drugs under development and dermatological skin care products, in terms of expert network and market resources, thereby potentially enhancing Dermavon’s market competitiveness and brand influence in the field of skin health.

 

More Information About Ruxolitinib Phosphate Cream

Ruxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte. In China, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. In the U.S., ruxolitinib phosphate cream is the first topical JAK inhibitor approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of non-segmental vitiligo in patients aged 12 years and older, and for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable[2]. In Europe, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age[3].

 

The Group, through its subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside of Mainland China to the Group (excluding Dermavon and its subsidiary).

 

Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream, marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte.

 

 

About CMS

 

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

 

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

 

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

 

Reference:

1. China Insights Consultancy’s industrial report

2. The U.S. FDA approval information can be found on the Incyte official website, as follows:

https://investor.incyte.com/news-releases/news-release-details/incyte-announces-additional-fda-approval-opzelurar-ruxolitinib

3. The EMA approval information can be found on the Incyte official website, as follows:

https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar

 

 

CMS Disclaimer and Forward-Looking Statements

 

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Groups market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

 

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Scientology Church members Marked World Health Day in Europe and Beyond

Published

on

Scientology Marks World Health Day Through Drug Prevention, Blood Donation and Community Health Initiatives

Brussels, Brussels, Belgium, 16th Apr 2026 — Churches of Scientology in several countries marked World Health Day 2026 through a range of activities intended to support both physical well-being and social responsibility, underscoring the place health holds within Scientology’s broader social betterment and humanitarian efforts.

Scientology Church members Marked World Health Day in Europe and Beyond

While the forms of observance differed from one community to another, the underlying theme was consistent: health was approached not only as a medical matter, but as something closely connected to knowledge, responsibility, human dignity and the ability of individuals to lead stable and constructive lives. In Scientology, that understanding has long informed both religious practice and a range of community-based initiatives inspired by founder L. Ron Hubbard.

This year’s observances included drug prevention programming, blood donation efforts and other health-oriented local activities shaped according to the needs of each community. Together, they reflected a practical view shared across many Scientology churches: that support for health can take different forms, from prevention and education to direct assistance and volunteer service.

A broad view of health

For Scientology, concern for health has never been limited to physical condition alone. The Church’s religious teachings and humanitarian programs have long linked personal well-being with ethical conduct, clarity of thought, responsibility and care for others. Physical and spiritual health are therefore seen not as separate matters, but as closely related dimensions of a person’s ability to live productively and contribute to society.

This perspective helps explain why health-related initiatives have become a recurring feature of Scientology’s public-interest activities. Programs dealing with drug prevention, moral values, community service and volunteer assistance all rest, in different ways, on the idea that healthier individuals are better able to build healthier communities.

One of the most visible World Health Day initiatives this year was a special marathon broadcast on Scientology Network on April 7. The programming highlighted the work of the Foundation for a Drug-Free World, a long-running drug education initiative that provides factual information about drugs and their effects so that young people and adults can make informed choices.

The marathon included episodes of Voices for Humanity, public service announcements addressing the dangers of drug use, and material connected to The Truth About Drugs campaign. The focus on prevention reflected a central principle in Scientology-supported social action: that many forms of suffering are best addressed before they take root.

Drug prevention has therefore remained one of the best-known areas of Scientology’s social engagement, particularly through partnerships with schools, educators, youth groups and community organizations. By emphasizing factual information rather than sensationalism, these initiatives seek to help individuals avoid patterns of dependency that can damage health, family stability and social cohesion.

Different churches, different forms of service

World Health Day was also marked through more direct forms of civic solidarity. In Milan, for example, the Church of Scientology hosted a blood donation day on April 9 in cooperation with AVIS Milano, part of the wider Italian Association of Blood Volunteers. The initiative continued a collaboration already established over the years and repeated several times annually.

For the occasion, an AVIS mobile blood collection unit was received at the Church’s facilities in Viale Fulvio Testi, allowing long-time donor Volunteer Ministers to continue giving blood regularly while also giving newer volunteers an opportunity to begin participating in blood donation as a form of community service. The event unfolded in a spirit of participation and awareness, with a simple but essential purpose: helping support a health system that depends on regular voluntary donations.

That initiative in Milan illustrated how local Scientology communities can cooperate with civic and healthcare-oriented organizations in practical ways that respond to immediate social needs. Blood donation remains one of the clearest examples of how ordinary citizens can directly support medical care and save lives. In this context, it also reflected a broader understanding that public health is strengthened not only by institutions, but by communities willing to act in a spirit of solidarity.

Other churches and groups marked the day in ways suited to their local environments. In some places, education and prevention were the primary focus. In others, practical acts of support, volunteer engagement and public awareness took center stage. This diversity of responses reflected the Church’s view that health is not addressed only in clinics or hospitals, but also through the everyday choices, habits and responsibilities that shape both personal and collective life.

The role of Scientology Volunteer Ministers in some of these activities also highlighted a long-standing emphasis on service. The Volunteer Minister program, known for providing practical assistance in community settings and times of need, approaches help in a broad sense, including physical support, moral encouragement and attention to spiritual well-being.

Health as a foundation for social betterment

The different World Health Day observances ultimately pointed to the same idea: that health is foundational to human flourishing and therefore central to any serious effort at social reform and social betterment. A person affected by drug abuse, poor health or social neglect is less able to exercise freedom, judgment and responsibility. A person supported by prevention, education and community care is better placed to live with dignity and to contribute positively to others.

This is why Scientology communities have long considered support for physical and spiritual health to be a cornerstone of their wider social engagement. Whether through drug education, blood donation, volunteer service or other local initiatives, these efforts are intended to strengthen the conditions in which individuals and communities can thrive.

Ivan Arjona, Scientology’s representative to the European Union, the OSCE, the Council of Europe and the United Nations, said the various observances of World Health Day reflected a principle with strong relevance across Europe.

“World Health Day offers an opportunity to remember that health is both physical and human,” Arjona said. “A society protects health not only through medicine and treatment, important as those are, but also through prevention, education, solidarity and the strengthening of personal responsibility. When communities work to prevent drug abuse, support blood donation or engage in local health-oriented service, they are helping defend both well-being and human dignity.”

He added: “The common thread is care for life and respect for the individual. Across Europe, these are deeply rooted civic values. Activities that strengthen the body, protect the mind and support responsible citizenship also strengthen the social fabric, and that is why this work matters.”

At a time when many societies are facing pressure on healthcare systems, concern over addiction and broader questions about resilience and social cohesion, these observances offered a reminder that community-based action still has an important role to play. Whether through factual education about drugs, direct support for blood banks or other locally organized health initiatives, Scientology communities used World Health Day to affirm a consistent principle: that health is essential to individual dignity, and that supporting it is both a personal and a civic responsibility.

The Church of Scientology, its churches, missions, groups and members are present across the European continent. Scientology Europe reports a continent-wide presence through more than 140 churches, missions and affiliated groups in at least 27 European nations, alongside thousands of community-based social betterment and reform initiatives focused on education, prevention and neighbourhood-level support, inspired by the work of Scientology founder L. Ron Hubbard.

Within Europe’s diverse national frameworks for religion, the Church’s recognitions continue to expand, with administrative and judicial authorities in Spain, Portugal, Sweden, the Netherlands, Italy, Germany Slovakia and others, as well as the European Court of Human Rights, having addressed and acknowledged Scientology communities as protected by the national and international provisions of Freedom of Religion or belief.

Media Contact

Organization: European Office Church of Scientology for Public Affairs and Human Rights

Contact Person: Ivan Arjona

Website: https://www.scientologyeurope.org

Email: Send Email

Address:Boulevard de Waterloo 103

City: Brussels

State: Brussels

Country:Belgium

Release id:44098

The post Scientology Church members Marked World Health Day in Europe and Beyond appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

New Pet-Friendly Sober Living Homes Open in Los Angeles, With Option to Bring a Pet to Sober Living

Published

on

Los Angeles, CA, United States, 16th Apr 2026 — Paws in Recovery has officially launched pawsinrecovery.com, introducing a first-of-its-kind network of pet-friendly sober living homes in Los Angeles for both men and women. With locations in Mid-City and on the west side of LA, Paws in Recovery is built on a straightforward idea: that the presence of a beloved pet during the earliest and most vulnerable days of sobriety can make a meaningful difference in whether someone stays the course. The homes are designed as comfortable, structured sober living environments that follow a traditional 12-step approach. They are not a substitute for treatment, and they make no claims to be. What they offer is something just as important — a safe, accountable, and genuinely supportive place to land after treatment ends, where residents do not have to choose between their sobriety and the animal companion who may have been with them through it all.

The Simple Case for Keeping Pets in the Picture

For many people entering recovery, leaving a pet behind is not just an inconvenience. It is a source of genuine grief and anxiety that can become an obstacle to seeking help in the first place. Studies and firsthand accounts have long pointed to the bond between humans and animals as a source of emotional grounding, reduced stress, and consistent routine — all things that matter enormously in early sobriety.

At Paws in Recovery, the founding team believes that physical touch, presence, and the quiet companionship of an animal can support a person’s ability to stay present, stay calm, and stay committed to the work of recovery. There is something steadying about caring for another living thing when your own world feels uncertain. That daily responsibility, that warmth, and that uncomplicated affection can act as an anchor in ways that are hard to replicate.

This is not an abstract belief. It is the reason the homes were built the way they were.

What Residents Can Expect

Paws in Recovery currently operates separate homes for men and women, with locations in Mid-City Los Angeles and on the west side of the city. Both homes are modern, well-kept, and designed to feel like an actual home rather than a facility. Residents will find comfortable communal spaces, private and semi-private rooms, and a warm environment that encourages genuine connection among housemates.

Meals are included, which removes one of the logistical stressors that can distract early recovery residents from focusing on their program. Ample street parking is available at both locations, making it easy for residents and their visitors to come and go without the daily frustration that often comes with living in Los Angeles.

The program is rooted in the 12-step model, with house expectations around meeting attendance, accountability, and mutual respect among residents. Staff are present and engaged, providing the kind of consistent oversight that helps residents stay on track without creating an overly institutional atmosphere.

For those searching for a well reviewed sober living program in LA that does not ask them to leave their pet at the door, Paws in Recovery is one of the very few options currently available in the city.

Pets: What to Know Before Applying

Paws in Recovery welcomes small and medium-sized pets in most cases. In the majority of situations, residents are able to bring one or two animals with them when they move in. The team reviews each situation individually, taking into account the specific breed, the size and layout of the available space at the time of move-in, and the comfort and safety of all residents in the home.

While the goal is always to find a way to say yes, there are occasional circumstances where a specific animal may not be the right fit for the current home environment. The admissions team works directly with each prospective resident to understand their situation and explore every available option before any final decision is made.

The focus is on small and medium-sized pets. Dogs and cats are the most common, and the homes are set up with that in mind. Pet owners are expected to be responsible for their animals at all times, including feeding, exercise, and general care, which itself reinforces the kind of structure and daily routine that supports long-term sobriety.

Filling a Real Gap in the Los Angeles Recovery Housing Market

Los Angeles has no shortage of sober living options, but finding a pet-friendly sober living home in Los Angeles that also provides structure, meals, and a genuine sense of community has historically been a difficult task. Many homes that advertise themselves as pet-friendly have significant restrictions that make the option effectively unavailable to most applicants. Others lack the basics — consistent programming, a clean environment, accountability — that make sober living work.

Paws in Recovery was built specifically to close that gap. The founders came to this work through personal experience with recovery and a shared understanding of how isolating the early months can feel, particularly when someone has to leave behind the one relationship in their life that has never asked anything complicated of them.

For anyone researching affordable sober living options in West Los Angeles or looking for a structured sober living house in Mid-City LA, Paws in Recovery is accepting applications now for both the men’s and women’s homes.

How to Apply or Learn More

Prospective residents and their families can learn more about availability, house rules, and the pet policy by visiting www.pawsinrecovery.com. The admissions process is straightforward, and the team is available to answer questions about what to expect, what to bring, and how to get started.

Paws in Recovery is committed to being one of the most accessible and genuinely supportive sober living options available anywhere in Los Angeles. For anyone who has been putting off taking the next step because they could not figure out what to do with their dog or their cat, the answer is now a little simpler.

You can bring them with you.

Media Contact

Organization: Paws in Recovery

Contact Person: Alex Stanworth

Website: https://pawsinrecovery.com

Email: Send Email

Contact Number: +13102690878

City: Los Angeles

State: CA

Country:United States

Release id:44078

The post New Pet-Friendly Sober Living Homes Open in Los Angeles, With Option to Bring a Pet to Sober Living appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

HHO Carbon Clean Franchisee Files Complaints with Regulatory Agencies over Fraudulent Franchise Sales Practices by Paducah, KY based HHO Carbon Clean Systems, LLC and HHO Franchise, LLC

Published

on

Complaints were filed with the Federal Trade Commission, Kentucky Office of the Attorney General and North Dakota Securities Department over the sales practices used in the sale of a Kentucky franchise territory and a North Dakota franchise territory.  HHO Carbon Clean Systems is managed by Dean Owen, CPA of Paducah, KY and Jared English of Metropolis, IL.

Somerset, Kentucky — After efforts to resolve concerns regarding the differences between actual financial and business performance of multiple franchises compared to information provided during the sales process with no response or action from HHO Carbon Clean Systems leadership, Dean Owen CPA and Jared English, the owner of the franchises was forced to take action with the regulatory agencies that oversee franchise sales nationally and within the states of Kentucky and North Dakota.

During the sales process, HHO Carbon Clean Systems provided Mr. Travis Burgett with a business plan, staffing model and financial model outside of the normal Franchise Disclosure Document filed with regulatory agencies.  During his time as the operator of the two franchises, Mr. Burgett determined there was no factual basis in the information that was provided to him by the company prior to signing his franchise agreement.  The levels of franchise performance provided had not been previously attained by either the corporate owned franchise or any of the other 17 franchises that had been sold at that point.

Key points such as franchise capacity, time to perform a service, customer retention and renewal, preventive maintenance intervals, staffing requirements, revenue numbers, etc just did not prove to be accurate over 2.5 years of operations.

Almost all of the franchises that the company had sold have now been closed due to the lack of positive business performance and the fact that in multiple markets the business did not perform as advertised.

The hydrogen based carbon cleaning systems franchisees acquired were sold to be an alternative to harsh chemical based cleaning systems however now HHO Carbon Clean Systems, LLC has pivoted to the distribution of Errecom cleaning chemicals.

From the HHO Carbon Clean Systems web site (www.hhoccs.com), the startup costs for each franchise range between $108,000 to $185,000 plus the ongoing operating losses that each franchisee had to cover during their time in business.

“It is unfortunate that myself and dozens of other franchisees did not experience the business performance that was presented to us by Dean and Jared.  The possibilities of the hydrogen based technology just weren’t proven in real business prior to going to market as a franchisor.” – Travis Burgett, owner HHO of Southern KY and HHO of North Dakota

HHO Carbon Clean Systems, LLC is located at 3060 John L Puryear Drive in Paducah, KY and sells hydrogen based carbon cleaning systems for combustion engines including passenger cars and trucks, diesel trucks and commercial vehicles. www.hhoccs.com

HHO of Southern KY operates a franchise territory in south central Kentucky and has been in operation since August of 2023.

HHO of North Dakota operated as a franchise covering the entire state of North Dakota from February of 2024 until March of 2025.

Media Contact Information

  • Contact Name: Travis Burgett
  • Title: Owner, HHO of Southern KY and HHO of North Dakota
  • Email: travisb@hhoccs.com
  • Phone: 859-533-2205
  • Website: www.hhoccs.com

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST